home.social

#cardioderm — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #cardioderm, aggregated by home.social.

  1. ScienceOpen @[email protected] ·

    📄 'Treatment of Plaque Psoriasis with Guselkumab Reduces Systemic Inflammatory Burden as Measured by Neutrophil/Lymphocyte Ratio, Platelet/Lymphocyte Ratio, and Monocyte/Lymphocyte Ratio: A post hoc Analysis of Three Randomised Clinical Trials' - an article in the #KargerPublishers research collection on #ScienceOpen:

    🔎🔗 scienceopen.com/document?vid=a

    #PlaquePsoriasis #Guselkumab #SystemicInflammation #CardioDerm #IL23Inhibitor #CardiovascularRisk

    #guselkumab #systemicinflammation #cardioderm #il23inhibitor #cardiovascularrisk #kargerpublishers
  2. ScienceOpen @[email protected] ·

    📄 'Treatment of Plaque Psoriasis with Guselkumab Reduces Systemic Inflammatory Burden as Measured by Neutrophil/Lymphocyte Ratio, Platelet/Lymphocyte Ratio, and Monocyte/Lymphocyte Ratio: A post hoc Analysis of Three Randomised Clinical Trials' - an article in the #KargerPublishers research collection on #ScienceOpen:

    🔎🔗 scienceopen.com/document?vid=a

    #PlaquePsoriasis #Guselkumab #SystemicInflammation #CardioDerm #IL23Inhibitor #CardiovascularRisk

    #guselkumab #systemicinflammation #cardioderm #il23inhibitor #cardiovascularrisk #kargerpublishers
  3. ScienceOpen @[email protected] ·

    📄 'Treatment of Plaque Psoriasis with Guselkumab Reduces Systemic Inflammatory Burden as Measured by Neutrophil/Lymphocyte Ratio, Platelet/Lymphocyte Ratio, and Monocyte/Lymphocyte Ratio: A post hoc Analysis of Three Randomised Clinical Trials' - an article in the #KargerPublishers research collection on #ScienceOpen:

    🔎🔗 scienceopen.com/document?vid=a

    #PlaquePsoriasis #Guselkumab #SystemicInflammation #CardioDerm #IL23Inhibitor #CardiovascularRisk

    #plaquepsoriasis #scienceopen #kargerpublishers #cardiovascularrisk #il23inhibitor #cardioderm